Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27221-27230 Newer>

The Motley Fool November 12, 2007 Tom Taulli	American Public Education's IPO Invasion Shares of the online educator skyrocket 80% on it's IPO. The company differentiates itself from its competitors by marketing to the military and public-service arena.
The Motley Fool November 12, 2007 Seth Jayson	The Lesson From ETrade In its quest for growth, ETrade put far too much of its asset base into residential real estate loans or related derivatives -- at the top of a since-crumbled market. The result? Shares that have tumbled 60% and an analyst's prediction of bankruptcy.
The Motley Fool November 12, 2007 Rick Aristotle Munarriz	4 Stocks That Took a Hike These companies have recently raised their dividends: Emerson Electric... Strayer... DeVry... AmerisourceBergen...
The Motley Fool November 12, 2007 Charly Travers	The Value of Myriad's Genes Myriad Genetics is unique in the biotech industry because it has a profitable diagnostics business to support its drug research and development efforts, as well as attractive prospects in its pipeline. Investors, take note.
The Motley Fool November 12, 2007 Brian Lawler	Vanda Gets Set for a Busy 2008 Although it has no marketed products, Vanda Pharmaceuticals third-quarter reports set the stage for an exciting 2008. Investors. take note.
The Motley Fool November 12, 2007 Rich Smith	Foolish Forecast: La-Z-Boy Unstuffed In advance of earnings reports, analysts expect the furniture manufacturer to show a slide in sales and a slight rise in profits.
The Motley Fool November 12, 2007 Toby Shute	Ethanol's Messy Fall All ethanol companies are not created equally. Compare some of the major producers: Aventine Renewable Energy... The Andersons... Archer Daniels Midland... Pacific Ethanol...
The Motley Fool November 12, 2007 Michael Leibert	Citigroup's Not Dead Yet Citigroup's shares will undoubtedly remain under pressure while the market waits for a resolution to this credit crisis. Nevertheless, the bank's $2.4 trillion balance sheet is well-equipped to handle the pain that is being inflicted on most of the financial-services sector.
The Motley Fool November 12, 2007 Rick Aristotle Munarriz	How Safe Is Your Broker? Shares of the online discount broker E*Trade take a 50% tumble after an analyst's bearish warning on the company.
The Motley Fool November 12, 2007 Brian Lawler	What's New at PDL BioPharma? The past few volatile months are reflected in the third-quarter results from PDL BioPharma. The future, however, may be smoother. Investors, take note.
<Older 27221-27230 Newer> Return to current articles.